ArticleFrontiers in medicine2026
The impact of individualized short-term prehabilitation on perioperative complications and inflammatory markers in pancreaticoduodenectomy: a single-center historical cohort study.
Article in Frontiers in medicine, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Prehabilitation has emerged as a promising strategy to enhance physiological reserve and improve surgical outcomes. This study aimed to evaluate the impact of a short-term prehabilitation program on perioperative complications and inflammatory responses in patients undergoing pancreaticoduodenectomy (PD). Methods: Consecutive patients scheduled for PD between October 2024 and October 2025 were assessed for eligibility for the prehabilitation program. The intervention group underwent a minimum two-week, individualized, multimodal prehabilitation program involving physical exercise, nutritional optimization, and psychological support. A historical control cohort was established for comparison, comprising patients who underwent PD without prehabilitation between July 2023 to September 2024. Postoperative outcomes, including postoperative pancreatic fistula (POPF), delayed gastric emptying (DGE), length of hospital stay, readmission rates, mortality, and inflammatory markers (white blood cell count, C-reactive protein [CRP], and neutrophil -to-lymphocyte ratio[NLR]), were systematically recorded. Results: A total of 63 patients successfully completed the prehabilitation program. Significant improvements were observed in functional capacity, evidenced by increased 6-min walk distance (6MWD) (from 505.84 ± 65.95 m to 546.30 ± 56.49 m; Conclusion: Short-term prehabilitation attenuates the perioperative blood cell and CRP response and improves functional capacity and quality of life, but it does not significantly reduce postoperative complication rates in this cohort.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.